Zacks.com on MSN
EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales
Exelixis posts strong Q3 results with earnings and revenue beats, boosted by Cabometyx sales, and narrows 2025 guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback